Novel mutations in TRIP13 lead to female infertility with oocyte maturation arrest
Received date: 2023-02-01
Revised date: 2023-03-30
Online published: 2023-04-21
Supported by
National Natural Science Foundation of China(81901473);Scientific Research Foundation of Reproductive and Genetic Hospital of China International Trust Investment Corporation (CITIC) Xiangya(YNXM-201810)
Oocyte maturation arrest (OMA) refers to a rare clinical phenomenon of oocyte maturation disorder caused by abnormal meiosis, which is also one of the primary causes of female infertility. The clinical manifestations of these patients are often characterized with failure to obtain mature oocytes after repeated ovulation stimulation and/or induced in vitro maturation. To date, mutations in PATL2, TUBB8 and TRIP13 have been demonstrated to be associated with OMA, but studies on the genetic-based factors and mechanisms of OMA are still incomplete. In this study, peripheral blood from 35 primary infertile women characterized with recurrent OMA during assisted reproductive technology (ART) were subjected to whole-exome sequencing (WES). By using Sanger sequencing and co-segregated analysis, we identified four pathogenic variants in TRIP13. Proband 1 had a homozygous missense mutation of c.859A>G appeared on the 9th exon, which resulted in substitution of Ile287 to valine (p.Ile287Val); proband 2 had a homozygous missense mutation of c.77A>G on the 1st exon, which resulted in substitution of His26 to arginine (p.His26Arg); and proband 3 had compound heterozygous mutations of c.409G>A and c.1150A>G on the 4th and 12th exon, which resulted in the substitutions of Asp137 to asparagine (p.Asp137Asn) and Ser384 to glycine (p.Ser384Gly) in the encoded protein respectively. Three of these mutations have not been reported previously. Further, transfection of plasmids harboring the respective mutated TRIP13 in HeLa cells resulted in changes in TRIP13 expression and abnormal cell proliferation as demonstrated by western blotting and cell proliferation assay respectively. This study further summarizes the TRIP13 mutations reported previously and expands the mutation spectrum of TRIP13 pathogenic variants, thereby providing a valuable reference for further research on the pathogenic mechanism of OMA associated with TRIP13 mutations.
Key words： oocyte maturation arrest; TRIP13; meiosis; female infertility
Xiangjiang Lv, Jing Guo, Ge Lin . Novel mutations in TRIP13 lead to female infertility with oocyte maturation arrest[J]. Hereditas(Beijing), 2023 , 45(6) : 514 -525 . DOI: 10.16288/j.yczz.23-022
| [1] | Guerri G, Maniscalchi T, Barati S, Gerli S, Di Renzo GC, Della Morte C, Marceddu G, Casadei A, Laganà AS, Sturla D, Ghezzi F, Garzon S, Unfer V, Bertelli M. Non-syndromic monogenic female infertility. Acta Biomed, 2019, 90(10-S): 68-74. |
| [2] | De Vos M, Grynberg M, Ho TM, Yuan Y, Albertini DF, Gilchrist RB. Perspectives on the development and future of oocyte IVM in clinical practice. J Assist Reprod Genet, 2021, 38(6): 1265-1280. |
| [3] | Fei CF, Zhou LQ. Gene mutations impede oocyte maturation, fertilization, and early embryonic development. Bioessays, 2022, 44(10): e2200007. |
| [4] | Jiao SY, Yang YH, Chen SR. Molecular genetics of infertility: loss-of-function mutations in humans and corresponding knockout/mutated mice. Hum Reprod Update, 2021, 27(1): 154-189. |
| [5] | Sang Q, Zhou Z, Mu J, Wang L. Genetic factors as potential molecular markers of human oocyte and embryo quality. J Assist Reprod Genet, 2021, 38(5): 993-1002. |
| [6] | Zhang ZH, Li B, Fu J, Li R, Diao FY, Li CH, Chen BB, Du J, Zhou Z, Mu J, Yan Z, Wu L, Liu S, Wang WJ, Zhao L, Dong J, He L, Liang XZ, Kuang YP, Sun XX, Sang Q, Wang L. Bi-allelic missense pathogenic variants in TRIP13 cause female infertility characterized by oocyte maturation arrest. Am J Hum Genet, 2020, 107(1): 15-23. |
| [7] | Cao QQ, Zhao C, Wang CJ, Cai LB, Xia M, Zhang XL, Han J, Xu YY, Zhang JQ, Ling XF, Ma X, Huo R. The recurrent mutation in PATL2 inhibits its degradation thus causing female infertility characterized by oocyte maturation defect through regulation of the mos-mapk pathway. Front Cell Dev Biol, 2021, 9: 628649. |
| [8] | Christou-Kent M, Kherraf ZE, Amiri-Yekta A, Le Blévec E, Karaouzène T, Conne B, Escoffier J, Assou S, Guttin A, Lambert E, Martinez G, Boguenet M, Fourati Ben Mustapha S, Cedrin Durnerin I, Halouani L, Marrakchi O, Makni M, Latrous H, Kharouf M, Coutton C, Thierry-Mieg N, Nef S, Bottari SP, Zouari R, Issartel JP, Ray PF, Arnoult C. PATL2 is a key actor of oocyte maturation whose invalidation causes infertility in women and mice. EMBO Mol Med, 2018, 10(5): e8515. |
| [9] | Feng RZ, Yan Z, Li B, Yu M, Sang Q, Tian GL, Xu Y, Chen BB, Qu RG, Sun ZG, Sun XX, Jin L, He L, Kuang YP, Cowan NJ, Wang L. Mutations in TUBB8 cause a multiplicity of phenotypes in human oocytes and early embryos. J Med Genet, 2016, 53(10): 662-71. |
| [10] | Cao TQ, Guo J, Xu Y, Lin XF, Deng WF, Cheng LZ, Zhao H, Jiang S, Gao M, Huang JJ, Xu YW. Two mutations in TUBB8 cause developmental arrest in human oocytes and early embryos. Reprod Biomed Online, 2021, 43(5): 891-898. |
| [11] | Agarwal S, Behring M, Kim HG, Chandrashekar DS, Chakravarthi BVSK, Gupta N, Bajpai P, Elkholy A, Al Diffalha S, Datta PK, Heslin MJ, Varambally S, Manne U. TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status. Mol Oncol, 2020, 14(12): 3007-3029. |
| [12] | Zhang GH, Zhu QZ, Fu G, Hou JB, Hu XS, Cao JJ, Peng W, Wang XW, Chen F, Cui HJ. TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis. Br J Cancer, 2019, 121(12): 1069-1078. |
| [13] | Ma HT, Poon RYC. TRIP 13 functions in the establishment of the spindle assembly checkpoint by replenishing O-MAD2. Cell Rep, 2018, 22(6): 1439-1450. |
| [14] | Ma HT, Poon RYC. TRIP13 regulates both the activation and inactivation of the spindle-assembly checkpoint. Cell Rep, 2016, 14(5): 1086-1099. |
| [15] | Vader G. Pch2(TRIP13): controlling cell division through regulation of HORMA domains. Chromosoma, 2015, 124(3): 333-339. |
| [16] | Hu HL, Zhang SP, Guo J, Meng F, Chen XQ, Gong F, Lu GX, Zheng W, Lin G. Identification of novel variants of thyroid hormone receptor interaction protein 13 that cause female infertility characterized by zygotic cleavage failure. Front Physiol, 2022, 13: 899149. |
| [17] | Lu SC, Guo MJ, Fan ZM, Chen Y, Shi XQ, Gu CY, Yang Y. Elevated TRIP13 drives cell proliferation and drug resistance in bladder cancer. Am J Transl Res, 2019, 11(7): 4397-4410. |
| [18] | Yost S, de Wolf B, Hanks S, Zachariou A, Marcozzi C, Clarke M, de Voer R, Etemad B, Uijttewaal E, Ramsay E, Wylie H, Elliott A, Picton S, Smith A, Smithson S, Seal S, Ruark E, Houge G, Pines J, Kops GJPL, Rahman N. Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation. Nat Genet, 2017, 49(7): 1148-1151. |
| [19] | Biswas L, Tyc K, El Yakoubi W, Morgan K, Xing JC, Schindler K. Meiosis interrupted: the genetics of female infertility via meiotic failure. Reproduction, 2021, 161(2): R13-R35. |
| [20] | Feng RZ, Sang Q, Kuang YP, Sun XX, Yan Z, Zhang SZ, Shi JZ, Tian GL, Luchniak A, Fukuda Y, Li B, Yu M, Chen JL, Xu Y, Guo L, Qu RG, Wang XQ, Sun ZG, Liu M, Shi HJ, Wang HY, Feng Y, Shao RJ, Chai RJ, Li QL, Xing QH, Zhang R, Nogales E, Jin L, He L, Gupta ML Jr, Cowan NJ, Wang L. Mutations in TUBB8 and human oocyte meiotic arrest. N Engl J Med, 2016, 374(3): 223-232. |
| [21] | Masciarelli S, Horner K, Liu C, Park SH, Hinckley M, Hockman S, Nedachi T, Jin C, Conti M, Manganiello V. Cyclic nucleotide phosphodiesterase 3A-deficient mice as a model of female infertility. J Clin Invest, 2004, 114(2): 196-205. |
| [22] | Oh JS, Han SJ, Conti M. Wee1B, Myt1, and Cdc25 function in distinct compartments of the mouse oocyte to control meiotic resumption. J Cell Biol, 2010, 188(2): 199-207. |
| [23] | Eytan E, Wang KX, Miniowitz-Shemtov S, Sitry-Shevah D, Kaisari S, Yen TJ, Liu ST, Hershko A. Disassembly of mitotic checkpoint complexes by the joint action of the AAA-ATPase TRIP13 and p31(comet). Proc Natl Acad Sci USA, 2014, 111(33): 12019-12024. |
| [24] | Gu YJ, Desai A, Corbett KD. Evolutionary dynamics and molecular mechanisms of HORMA domain protein signaling. Annu Rev Biochem, 2022, 91: 541-569. |
| [25] | Roig I, Dowdle JA, Toth A, de Rooij DG, Jasin M, Keeney S. Mouse TRIP13/PCH2 is required for recombination and normal higher-order chromosome structure during meiosis. PLoS Genet, 2010, 6(8): e1001062. |
| [26] | Li XCL, Schimenti JC. Mouse pachytene checkpoint 2 (trip13) is required for completing meiotic recombination but not synapsis. PLoS Genet, 2007, 3(8): e130. |
| [27] | Zhou XY, Shu XM. TRIP13 promotes proliferation and invasion of epithelial ovarian cancer cells through Notch signaling pathway. Eur Rev Med Pharmacol Sci, 2019, 23(2): 522-529. |
| [28] | Hat?rnaz ?, Hat?rnaz ES, Ellibe? Kaya A, Hat?rnaz K, Soyer ?al??kan C, Sezer ?, Dokuzeylül Güngor N, Demirel C, Baltac? V, Tan S, Dahan M. Oocyte maturation abnormalities - a systematic review of the evidence and mechanisms in a rare but difficult to manage fertility pheneomina. Turk J Obstet Gynecol, 2022, 19(1): 60-80. |
/
| 〈 |
|
〉 |
www.chinagene.cn
备案号：京ICP备09063187号
